<div id="readability-page-1"><p>Regal Partners Ltd purchased a new position in shares of  Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the third quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The firm purchased 101,714 shares of the company's stock, valued at approximately $7,547,000. Inspire Medical Systems accounts for approximately  0.5% of Regal Partners Ltd's investment portfolio, making the stock its 26th largest position. Regal Partners Ltd owned 0.35% of Inspire Medical Systems as of its most recent filing with the Securities &amp; Exchange Commission.</p><ul><li>Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market</li></ul><p>Other institutional investors have also recently bought and sold shares of the company. Texas Permanent School Fund Corp boosted its stake in shares of  Inspire Medical Systems by 42.2% during the 2nd quarter. Texas Permanent School Fund Corp now owns 40,042 shares of the company's stock worth $5,196,000 after acquiring an additional 11,892 shares during the period.  Y Intercept Hong Kong Ltd raised its stake in  Inspire Medical Systems by 553.1% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company's stock valued at $7,349,000 after acquiring an additional 83,883 shares during the period.  CW Advisors LLC raised its stake in  Inspire Medical Systems by 45.3% in the 2nd quarter. CW Advisors LLC now owns 49,960 shares of the company's stock valued at $6,484,000 after acquiring an additional 15,576 shares during the period.  Capital Fund Management S.A. lifted its holdings in  Inspire Medical Systems by 44.1% during the 2nd quarter. Capital Fund Management S.A. now owns 68,663 shares of the company's stock valued at $8,910,000 after purchasing an additional 21,021 shares during the last quarter.  Finally, Norges Bank acquired a new stake in  Inspire Medical Systems during the 2nd quarter valued at $31,066,000. Institutional investors and hedge funds own  94.91% of the company's stock. </p><h2>Inspire Medical Systems Stock Performance</h2><p>INSP stock opened at $63.01 on Friday. Inspire Medical Systems, Inc. has a 52 week low of $53.11 and a 52 week high of $189.49. The company has a market capitalization of $1.80 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 3.09 and a beta of 0.74. The company's 50-day simple moving average is $77.16 and its 200 day simple moving average is $87.18. </p><ul><li>Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy</li></ul><p>Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $1.65 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.96. The business had revenue of $269.08 million during the quarter, compared to analysts' expectations of $264.02 million. Inspire Medical Systems had a net margin of 15.95% and a return on equity of 10.96%. The business's revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.15 EPS.  On average, analysts forecast that  Inspire Medical Systems, Inc. will post 2.16 EPS for the current year. </p><h2>Analyst Ratings Changes</h2><p>Several equities analysts have commented on INSP shares. Morgan Stanley  set a $60.00 price objective on shares of Inspire Medical Systems in a report on Wednesday, February 18th. Oppenheimer downgraded shares of Inspire Medical Systems from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a report on Thursday, January 22nd. Weiss Ratings  reiterated a &#34;sell (d)&#34; rating on shares of Inspire Medical Systems in a research note on Monday, December 29th. Stifel Nicolaus cut their price objective on shares of Inspire Medical Systems from $95.00 to $85.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday. Finally, Wells Fargo &amp; Company  set a $70.00 target price on Inspire Medical Systems and gave the company an &#34;equal weight&#34; rating in a research report on Thursday, February 12th. Five investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one  has assigned  a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and a consensus price target of $104.24.</p><ul><li>Are Small Caps a Harbinger of Market Declines?</li></ul><p><b>Check Out Our Latest Report on INSP</b></p><h2>About Inspire Medical Systems</h2> (Free Report)<p>Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.  </p><p>The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.</p><h2>See Also</h2><ul><li>Five stocks we like better than Inspire Medical Systems</li><li>How JPMorgan's $8,000 Gold Call Will Leave Most Retirement Accounts Behind</li><li>Silver Is the New Oil—And the World’s Running Dry</li><li>Nvidia CEO Issues Bold Tesla Call</li><li>Elon’s BIGGEST breakthrough yet?</li><li>This makes me furious</li></ul><p><strong>Want to see what other hedge funds are holding INSP?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Inspire Medical Systems Right Now?</h2><p>Before you consider Inspire Medical Systems, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn't on the list.</p><p>While Inspire Medical Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SBIO

INSP

<p>Regal Partners Ltd has acquired a new position in Inspire Medical Systems, Inc. (NYSE:INSP), purchasing 101,714 shares valued at approximately $7.5 million, making it the 26th largest position in their portfolio. Other institutional investors have also increased their stakes in Inspire Medical Systems. The company's stock opened at $63.01, with a market cap of $1.80 billion and a PE ratio of 12.65. Analysts have mixed ratings on the stock, with an average rating of "Hold" and a consensus price target of $104.24.</p>

Market Beat

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Inspire Medical

VanEck Biotech ETF

iShares Biotechnology ETF

iShares US Medical Devices

SPDR S&P Health Equip

Regal Partners Ltd Buys New Holdings in Inspire Medical Systems, Inc. $INSP